We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-0.01%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$3.41B
AUM Growth
+$578M
Cap. Flow
+$847M
Cap. Flow %
24.86%
Top 10 Hldgs %
15.38%
Holding
1,378
New
421
Increased
275
Reduced
291
Closed
387

Sector Composition

Rank Sector Weight
1 Financials 18.07%
2 Consumer Discretionary 13.53%
3 Healthcare 13.37%
4 Technology 10.64%
5 Communication Services 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAP icon
201
Advance Auto Parts
AAP
$3.39B
$3.82M 0.11%
23,100
+21,700
+1,550% +$3.26M
EXC icon
202
Exelon
EXC
$46.6B
$3.78M 0.11%
109,816
-2,794
-2% -$93.8K
UNH icon
203
UnitedHealth
UNH
$383B
$3.78M 0.11%
17,400
+140
+0.8% +$33.8K
P
204
Everpure Inc
P
$25B
$3.77M 0.11%
222,500
+193,000
+654% +$3.03M
CVX icon
205
Chevron
CVX
$383B
$3.75M 0.11%
31,623
+28,313
+855% +$3.44M
ADVM
206
DELISTED
Adverum Biotechnologies
ADVM
$3.74M 0.11%
+68,670
New +$7.74M
HUBG icon
207
HUB Group
HUBG
$2.78B
$3.73M 0.11%
+160,486
New +$3.41M
ETR icon
208
Entergy
ETR
$50.4B
$3.72M 0.11%
63,400
+44,800
+241% +$2.45M
DG icon
209
Dollar General
DG
$28.1B
$3.7M 0.11%
23,300
-3,927
-14% -$568K
EIDX
210
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$3.55M 0.1%
98,600
+30,699
+45% +$1.2M
DGX icon
211
Quest Diagnostics
DGX
$25.9B
$3.54M 0.1%
+33,100
New +$3.4M
OFIX icon
212
Orthofix Medical
OFIX
$477M
$3.54M 0.1%
66,700
+49,600
+290% +$2.56M
SNPS icon
213
Synopsys
SNPS
$71.3B
$3.46M 0.1%
25,200
+12,663
+101% +$1.71M
TPTX
214
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$3.44M 0.1%
+91,600
New +$3.99M
MSM icon
215
MSC Industrial Direct
MSM
$6.78B
$3.42M 0.1%
+47,100
New +$3.3M
CHTR icon
216
Charter Communications
CHTR
$16.9B
$3.41M 0.1%
8,283
+4,551
+122% +$1.84M
BAX icon
217
Baxter International
BAX
$13.8B
$3.41M 0.1%
38,999
+30,819
+377% +$2.63M
PTLA
218
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3.4M 0.1%
126,965
+25,365
+25% +$712K
OXY icon
219
Occidental Petroleum
OXY
$55.6B
$3.38M 0.1%
76,054
+63,552
+508% +$3M
ADI icon
220
Analog Devices
ADI
$179B
$3.31M 0.1%
29,598
+14,884
+101% +$1.69M
EL icon
221
Estee Lauder
EL
$30.7B
$3.3M 0.1%
+16,592
New +$3.17M
TWLO icon
222
Twilio
TWLO
$29B
$3.27M 0.1%
29,748
+21,448
+258% +$2.78M
LNC icon
223
Lincoln National
LNC
$8.8B
$3.27M 0.1%
54,200
+4,276
+9% +$256K
TMX
224
DELISTED
Terminix Global Holdings, Inc.
TMX
$3.26M 0.1%
58,250
-110,550
-65% -$6.09M
ADBE icon
225
Adobe
ADBE
$98.5B
$3.23M 0.09%
11,700
-571
-5% -$167K

Similar funds

Schonfeld Strategic Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Schonfeld Strategic Advisors held 1,378 positions worth $3.41B, up 20% from $2.83B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Schonfeld Strategic Advisors deployed $847M of net new capital in Q3 2019, opening 421 new positions and adding to 275 existing holdings. Its largest new stake was Live Nation Entertainment: 265,765 shares worth $17.6M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vistra, an estimated $36.3M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2019 buy was Live Nation Entertainment: 265,765 shares worth $17.6M.
  • Schonfeld Strategic Advisors added most to Equitrans Midstream Corporation Common Stock in Q3 2019, an estimated $50.3M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2019 reduction was Vistra, cutting an estimated $36.3M.
  • Schonfeld Strategic Advisors fully exited TotalEnergies in Q3 2019, selling an estimated $30.7M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 15% of its $3.41B portfolio in Q3 2019.
  • Schonfeld Strategic Advisors opened 421 new positions and closed 387 in Q3 2019.
  • Schonfeld Strategic Advisors's portfolio value rose 20% quarter-over-quarter to $3.41B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.